Concomitant Pathogenic Mutations and Fusions of Driver Oncogenes in Tumors.
concomitant
fusion
leukemia
lung cancer
mutation
thyroid cancer
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2020
2020
Historique:
received:
21
03
2020
accepted:
27
11
2020
entrez:
1
2
2021
pubmed:
2
2
2021
medline:
2
2
2021
Statut:
epublish
Résumé
Driver oncogene alterations have always been one of leading causes in the process of occurrence and development of tumors. And the effects of driver oncogene alterations on tumorigenesis and progression in different kinds of tumors have been studied heatedly. And the roles that the driver oncogenes alterations play have been elucidated clearly in previous studies. The phenomenon of concomitant driver oncogenes mutations and driver genes fusions has gained much concentration in the past two decades. And a growing number of studies reported this phenomenon, either coexistence or mutually exclusivity. Here we reviewed on the phenomenon of concomitant mutations in three common types of carcinomas-lung cancer, thyroid cancer, and leukemia, which have been studied relatively more detailed and more general compared with others.
Identifiants
pubmed: 33520689
doi: 10.3389/fonc.2020.544579
pmc: PMC7844084
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
544579Informations de copyright
Copyright © 2021 Zhang, Dong and Yu.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Natl Cancer Inst. 2003 Apr 16;95(8):625-7
pubmed: 12697856
Lung Cancer. 2012 Aug;77(2):460-3
pubmed: 22622260
Cancer. 2012 Feb 1;118(3):729-39
pubmed: 21720997
Oncogene. 2003 Jul 17;22(29):4578-80
pubmed: 12881714
Mod Pathol. 2009 Apr;22(4):508-15
pubmed: 19234440
Chin J Cancer Res. 2015 Feb;27(1):2-12
pubmed: 25717220
Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):3030-5
pubmed: 19861517
Thyroid. 2014 Feb;24(2):254-9
pubmed: 23806056
Cell. 2014 Oct 23;159(3):676-90
pubmed: 25417114
Nature. 2009 Dec 24;462(7276):1005-10
pubmed: 20033038
J Natl Cancer Inst. 2007 Dec 5;99(23):1811-4
pubmed: 18042939
Nat Commun. 2015 May 27;6:7174
pubmed: 26013381
Nat Commun. 2014;5:3116
pubmed: 24445538
Anticancer Res. 2014 Oct;34(10):5229-40
pubmed: 25275015
BMC Cancer. 2012 Nov 26;12:558
pubmed: 23181703
JAMA. 2008 Jan 9;299(2):194-201
pubmed: 18182601
Thyroid. 2014 Aug;24(8):1256-66
pubmed: 24798740
Cancer Res. 2010 May 15;70(10):4123-32
pubmed: 20424115
Clin Cancer Res. 1998 Feb;4(2):287-94
pubmed: 9516913
J Pathol. 2018 Feb;244(2):215-226
pubmed: 29144541
J Clin Endocrinol Metab. 2000 Mar;85(3):1170-5
pubmed: 10720057
Lung Cancer. 2011 Apr;72(1):9-15
pubmed: 21272954
J Clin Endocrinol Metab. 2005 Apr;90(4):2364-9
pubmed: 15671095
J Thorac Oncol. 2010 Dec;5(12):2039-40
pubmed: 21102267
Nat Rev Endocrinol. 2016 Apr;12(4):192-202
pubmed: 26868437
Eur J Cancer. 2012 Jun;48(9):1299-311
pubmed: 22464348
J Thorac Oncol. 2008 Jan;3(1):13-7
pubmed: 18166835
Trends Mol Med. 2004 Oct;10(10):481-6
pubmed: 15464447
Nat Rev Mol Cell Biol. 2004 Nov;5(11):875-85
pubmed: 15520807
Lung Cancer. 2011 Feb;71(2):241-3
pubmed: 21168933
Blood. 2019 Mar 7;133(10):1140-1151
pubmed: 30610028
Cancer Res. 1997 May 1;57(9):1690-4
pubmed: 9135009
Clin Cancer Res. 2008 Jul 1;14(13):4275-83
pubmed: 18594010
Mol Oncol. 2014 Dec;8(8):1495-507
pubmed: 24962792
Clin Cancer Res. 2009 Jan 15;15(2):485-91
pubmed: 19147753
Blood. 2016 May 19;127(20):2498-501
pubmed: 26968532
Blood Adv. 2020 Oct 13;4(19):4623-4631
pubmed: 32991719
Cancer Res. 2011 Sep 15;71(18):6051-60
pubmed: 21791641
J Pathol. 2020 May;251(1):74-86
pubmed: 32162306
J Clin Oncol. 2009 Sep 10;27(26):4247-53
pubmed: 19667264
Clin Lung Cancer. 2019 Jul;20(4):e517-e530
pubmed: 31138506
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
pubmed: 21296855
Target Oncol. 2019 Apr;14(2):169-178
pubmed: 30888598
Leukemia. 2020 Jun;34(6):1553-1562
pubmed: 31896782
Cancer Res. 2003 Apr 1;63(7):1454-7
pubmed: 12670889
Clin Cancer Res. 2014 Mar 1;20(5):1383-92
pubmed: 24443522
N Engl J Med. 2013 May 30;368(22):2059-74
pubmed: 23634996
Nat Commun. 2016 Jun 02;7:11733
pubmed: 27252013
J Clin Oncol. 2009 Sep 10;27(26):4232-5
pubmed: 19667260
J Clin Endocrinol Metab. 2005 Dec;90(12):6373-9
pubmed: 16174717
Am J Surg Pathol. 2020 Feb;44(2):162-173
pubmed: 31567189
Oncotarget. 2017 Apr 26;8(35):59889-59900
pubmed: 28938691
N Engl J Med. 2016 Jun 9;374(23):2209-2221
pubmed: 27276561
Lancet Oncol. 2008 Jul;9(7):676-82
pubmed: 18598932
Oncology (Williston Park). 2010 Jan;24(1):40, 43
pubmed: 20187320
Nature. 1986 Feb 27-Mar 5;319(6056):743-8
pubmed: 2869410
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32
pubmed: 26808342
Annu Rev Pathol. 2011;6:479-507
pubmed: 21090969
Annu Rev Pathol. 2011;6:49-69
pubmed: 20887192
Endocr Relat Cancer. 2005 Jun;12(2):245-62
pubmed: 15947100
Oncotarget. 2016 Oct 4;7(40):65185-65195
pubmed: 27533086
Clin Lung Cancer. 2016 Jan;17(1):56-61
pubmed: 26381283
Mol Cell. 1999 Oct;4(4):511-8
pubmed: 10549283
Nat Genet. 2016 Dec;48(12):1551-1556
pubmed: 27798625
BMC Med Genomics. 2011 Oct 27;4:75
pubmed: 22032724
Arq Bras Endocrinol Metabol. 2007 Jul;51(5):736-47
pubmed: 17891237
Ann Oncol. 2015 Feb;26(2):348-54
pubmed: 25403583
Clin Cancer Res. 2013 Aug 1;19(15):4273-81
pubmed: 23729361
Endocr Regul. 2006 Dec;40(4):129-38
pubmed: 17201587
J Thorac Oncol. 2011 Nov;6(11):1962-3
pubmed: 22005476
Nature. 2007 Aug 2;448(7153):561-6
pubmed: 17625570
Clin Cancer Res. 2009 Aug 15;15(16):5216-23
pubmed: 19671850
Mod Pathol. 2020 Jan;33(1):38-46
pubmed: 31375766
J Thorac Oncol. 2015 May;10(5):778-783
pubmed: 25629635
J Clin Endocrinol Metab. 2007 Nov;92(11):4085-90
pubmed: 17785355
Lung Cancer. 2008 Aug;61(2):163-9
pubmed: 18242762
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
N Engl J Med. 2016 Dec 8;375(23):2306-2307
pubmed: 27959678
Front Oncol. 2014 Jul 16;4:182
pubmed: 25077070
Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19893-7
pubmed: 19064915
Clin Cancer Res. 2008 Oct 15;14(20):6618-24
pubmed: 18927303
Oncology (Williston Park). 2010 Jan;24(1):48-9
pubmed: 20187321
Cureus. 2016 Feb 26;8(2):e513
pubmed: 27026837
Cancer. 2009 Apr 15;115(8):1723-33
pubmed: 19170230
Ann Hematol. 2019 Jan;98(1):83-91
pubmed: 30251205
Cancer Res. 2017 Jul 15;77(14):3814-3822
pubmed: 28512242
Am J Surg Pathol. 2018 Aug;42(8):1052-1058
pubmed: 29683819
J Natl Cancer Inst. 2015 Nov 12;108(1):
pubmed: 26563355
Am J Surg Pathol. 2020 Sep;44(9):1224-1234
pubmed: 32804454
J Clin Endocrinol Metab. 2001 Jul;86(7):3211-6
pubmed: 11443191
Virchows Arch. 2013 Oct;463(4):583-91
pubmed: 23955278
Lung Cancer. 2014 Nov;86(2):291-5
pubmed: 25312989
Lancet. 2013 Mar 23;381(9871):1046-57
pubmed: 23668555
Cancer. 2005 Sep 1;104(5):943-51
pubmed: 16015630